Measuring baroreflex sensitivity from the gain function between arterial pressure and heart period

Area of Science:

• Cardiovascular Physiology
• Autonomic Nervous System Function
• Biomedical Signal Processing

Background:

• Baroreflex sensitivity (BRS) is a crucial indicator of autonomic cardiovascular regulation.
• Traditional BRS estimation using spectral analysis often fails in patients due to low coherence.
• The phenylephrine test (Phe-BRS) is an alternative but invasive method for BRS assessment.

Purpose of the Study:

• To evaluate an innovative whole-band average BRS (WBA-BRS) method for estimating baroreflex sensitivity.
• To assess the impact of abandoning the coherence criterion on BRS measurability.
• To compare WBA-BRS with phenylephrine-derived BRS (Phe-BRS) in normal subjects and patients with myocardial infarction (MI) and chronic heart failure (CHF).

Main Methods:

• Recorded systolic arterial pressure (SAP) and heart period (HP) in 19 normal subjects, 44 MI patients, and 45 CHF patients.
• Computed gain and coherence functions from spontaneous SAP and HP oscillations.
• Calculated WBA-BRS by averaging the gain function over the 0.04-0.15 Hz low-frequency band.

Main Results:

• WBA-BRS was successfully measured in all subjects, unlike the coherence-based method which had limited success in MI and CHF patients.
• WBA-BRS values differed significantly between normal subjects and MI/CHF patients.
• Correlations between WBA-BRS and Phe-BRS were significant across all groups, though WBA-BRS showed a tendency towards negative bias compared to Phe-BRS.

Conclusions:

• The WBA-BRS method standardizes BRS computation and substantially increases its measurability in patients with cardiovascular pathology.
• WBA-BRS offers a non-invasive, more reliable alternative to coherence-based spectral methods for BRS assessment.
• While WBA-BRS shows good agreement with Phe-BRS, its tendency for negative bias warrants consideration in clinical interpretation.